longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

IRhythm

IRTC

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -260.85, below the reasonable range, cheaper than 96.86% of the time in the past 5 years, and the industry ranks 158/174, the industry Median -0.93.

-260.85xP/E
$110.37Stock price
$-0.42Earnings per share
-260.85xP/E
Stock price$110.37Earnings per share$-0.42

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-31.21x
Typical range
-61.65x–-24.34x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAXUSBaxter
-11.42x141.71%$12.14B
GKOSUSGlaukos
-51.36x75.37%$9.66B
TFXUSTeleflex
-5.10x118.39%$5.26B
IRTCUSIRhythm
-260.85x71.96%$3.64B
PLSEUSPulse Biosciences
-42.67x27.55%$3.42B
BFLYUSButterfly Network
-31.84x34.41%$2.38B
AXGNUSAxogen
-65.39x26.89%$2.19B
ASSTUSStrive
-2.13x63.23%$2.08B
NVCRUSNovocure
-11.71x2.52%$1.74B
KMTSUSKestra Medical Tech
-10.73x0.94%$1.61B
ATECUSAlphatec
-14.08x41.67%$1.55B
DRTSUSAlpha Tau Medical
-14.73x--$1.36B
TNDMUSTandem Diabetes
-18.13x77.60%$1.15B
AORTUSArtivion
-340.88x266.67%$1.09B
ENOVUSEnovis
-0.93x100.97%$1.02B
BBNXUSBeta Bionics
-13.68x13.22%$998.09M
IARTUSIntegra LifeSciences
-136.27x109.42%$986.83M
PRCTUSPROCEPT BioRobotics
-8.95x3.47%$982.82M
CBLLUSCeribell
-13.78x35.15%$909.18M
SIBNUSSI-BONE
-55.38x8.85%$810.32M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.